Today's Change
+0.85%
AI Sentiment
59%
Sector AnalysisLive data
Materials Sector Outlook
The Materials sector is up 0.85% today with neutral sentiment across 14 recent news articles. Top movers include $CDTTW (+65.33%), $ERNAW (+63.87%), $TMCWW (+60.68%).
Bullish Factors
- No strong bullish signals detected
Risk Factors
- No strong bearish signals detected
Stocks in Materials
198 stocks| Symbol | Company | Change |
|---|---|---|
| $REVBW | Revelation Biosciences Inc - Warrants(10/01/2027) | +0.00% |
| $RVMDW | Revolution Medicines Inc - Warrants (17/12/2026) | +4.86% |
| $HUMAW | Humacyte Inc - Warrants (27/08/2026) | +5.13% |
| $NAMSW | NewAmsterdam Pharma Company NV - Warrants (15/11/2027) | +21.31% |
| $SABSW | SAB Biotherapeutics Inc - Warrants (25/07/2027) | +48.52% |
| $AIMDW | Ainos Inc - Warrants (29/07/2027) | -24.11% |
| $BFRIW | Biofrontera Inc - Warrants (27/10/2026) | +37.24% |
| $BCTXZ | BriaCell Therapeutics Corp Warrant | -13.56% |
| $ERNAW | Ernexa Therapeutics Inc Warrants | +63.87% |
| $BCTXL | BriaCell Therapeutics Corp Warrants | +7.53% |
| $CDIOW | Cardio Diagnostics Holdings Inc - Warrants (01/12/2026) | -11.72% |
| $CITR | General Enterprise Ventures Inc | +3.17% |
| $ASBPW | Aspire Biopharma Holdings Inc - Warrants (18/02/2030) | +7.88% |
| $JSPRW | Jasper Therapeutics Inc - Warrants (24/09/2026) | -15.64% |
| $SEE | Sealed Air Corp. | +0.00% |
Materials News
805 articles
The Motley Fool39d ago
Adaptive Biotech's President Trimmed Her Position. But what Remains is worth a look
GlobeNewswire Inc.39d ago
INOVIO DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Inovio Pharmaceuticals Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important April 7 Deadline in Securities Class Action – INO
GlobeNewswire Inc.39d ago
Curanex Provides Business Update in Connection with 2025 Annual Report as Phyto-N Advances Toward Planned IND Submission
GlobeNewswire Inc.39d ago
Artelo Biosciences Announces Closing of $11.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules
GlobeNewswire Inc.39d ago
Acoramidis Significantly Reduces the Risk of All-Cause and Cardiovascular Mortality in Patients with ATTR-CM through Month 54
GlobeNewswire Inc.39d ago
RARE FINAL DEADLINE: ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Ultragenyx Pharmaceutical Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important April 6 Deadline in Securities Class Action - RARE
GlobeNewswire Inc.40d ago
Deadline Alert: Soleno Therapeutics, Inc. (SLNO) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit
GlobeNewswire Inc.40d ago
Bronstein, Gewirtz & Grossman LLC Urges Inovio Pharmaceuticals, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
GlobeNewswire Inc.40d ago
RGNX Investors Have Opportunity to Lead REGENXBIO Inc. Securities Fraud Lawsuit with the Schall Law Firm
GlobeNewswire Inc.40d ago
Teva gewinnt an Dynamik im Biosimilar-Geschäft mit der FDA-Zulassung für PONLIMSI™ (Denosumab-adet) und der Annahme von parallelen Zulassungsanträgen für einen Biosimilar-Kandidaten zu Xolair® (Omalizumab)
Market Sentiment
Neutral
59% Sentiment Score
Sector Stats
Total Stocks198
News Today14
Avg Volume1.3M
AI SentimentNeutral